This is a preview of subscription content, log in via an institution to check access.
References
Fujii AM, Patel SM, Allen R, Doros G, Guo CY, Testa S . Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome. J Perinatol 2010. Advance online publication 25 March 2010; doi:10.1038/jp.2010.20.
Fujii A, Allen R, Doros G, O’Brien S . Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome. J Perinatol 2010. Advance online publication 25 March 2010; doi:10.1038/jp.2010.21.
Holm B, Cummings JJ . Is there evidence for a mortality difference between exogenous surfactant preparations in neonatal RDS? J Appl Res 2008; 8 (2): 78–83.
Köksal N, Akpinar R, Cetinkaya M . Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome. Turk J Pediatr 2009; 51 (6): 556–564.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares that he is also an employee of a company that manufactures surfactant.
Rights and permissions
About this article
Cite this article
Lutchman, D. Have we been down this road before?. J Perinatol 30, 698–699 (2010). https://doi.org/10.1038/jp.2010.88
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2010.88
- Springer Nature America, Inc.
This article is cited by
-
Porcine versus bovine surfactant therapy for RDS in preterm neonates: pragmatic meta-analysis and review of physiopathological plausibility of the effects on extra-pulmonary outcomes
Respiratory Research (2020)
-
Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes
Respiratory Research (2019)